Products
Home > Therapeutic Peptides > APIs > Felypressin Acetate

If you find Creative Peptides is useful to satisfy your needs, please do not hesitate to contact us!

Felypressin Acetate

CAT#
10-101-84
Synonyms/Alias
Octapressin; Octopressin; Phelypressin; Phenylalanine Lysine Vasopressin; PLV-2; Vasopressin, Phenylalanyl-Lysyl
CAS No.
56-59-7
Sequence
H-Cys-Phe-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 acetate salt (Disulfide bond)
M.W/Mr.
1040.22
Molecular Formula
C46H65N13O11S2
Source
Synthetic
Long-term Storage Conditions
−20°C
Application
Felypressin is a non-catecholamine vasoconstrictor that is chemically related to vasopressin, the posterior pituitary hormone. It is added to some local anaesthetics.
Description
Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found in various sites around the body. The major points include the CNS, Liver, Anterior Pituitary, Muscle (both vascular and non-vascular smooth muscle), and Platelets (CLAMP).
Areas of Interest
Vasoconstrictor & Anaesthetic

Useful Tools

Felypressin, a synthetic analogue of vasopressin (AVP), has been widely used as a substitute for epinephrine (EPI) in anesthetic solutions to promote local vasoconstriction during medical and dental practices. Because it has no interaction with adrenergic receptors, it is suggested that felypressin has fewer side effects than EPI. Hence, Felypressin causes fewer cardiovascular and metabolic side effects, and it has a higher median lethal dose (LD50) than EPI. However, the mechanisms and the receptors used by felypressin to induce cardiovascular effects are unknown, and very few studies have been conducted on its possible systemic effects.

Cardiovascular effects of felypressin (FEL) were studied in Wistar rats. Heart rate and mean arterial pressure measurements were taken in awake rats treated with vasopressin (AVP), FEL, or epinephrine (EPI). Each group received either an intravenous (IV) or an intracerebroventricular V1 receptor antagonist, saline, area postrema removal, or sham surgery. Analysis of variance and Student-Newman-Keuls (P < .05) were applied. Felypressin and AVP induced a pressor effect, and bradycardia was inhibited by IV V1 antagonist. Intracerebroventricular V1 antagonist and area postrema removal enhanced their pressor effects. Epinephrine induced a higher pressor effect and a similar bradycardia that was not affected by the treatments. It was concluded that FEL depends on V1 receptors to induce pressor and bradycardic effects, and that it produces a high relationship between bradycardia and mean arterial pressure variation depending on area postrema and central V1 receptors. These effects are potentially less harmful to the cardiovascular system than the effects of EPI.

Cecanho, R., De Luca Jr, L. A., & Ranali, J. (2006). Cardiovascular effects of felypressin. Anesthesia progress, 53(4), 119-125.

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry
  • Please enter the code "peptides"

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

Follow us on:

Copyright © 2008 - Creative Peptides. All rights reserved.

USA

Address: 45-16 Ramsey Road, Shirley, NY 11967, USA

Tel: 1-631-624-4882

Fax: 1-631-614-7828

E-Mail:

Europe

Tel: 44-207-097-1828

E-Mail: